Q2 2025 · 1 tracked holders Snapshot · 16 Nov 2026 Export CSV
Security file · CUSIP 761299AB2

TRAVERE THERAPEUTICS INC

TRAVERE THERAPEUTICS INC · held by 1 tracked manager in Q2 2025.

Tracked holders · Q2 2025
1
+0 vs Q4 2024
Aggregate reported value
$1.36M
sum of holders' reported positions
New holders this quarter
0
1 added · 0 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q2 2025
ManagerWeight SharesΔ shares Entry Return ValueActivity
1 Howard Marks - Oaktree Capital Managementfiled 13 Aug ET 0.02% 1.38M +33.3% — — $1.36M Added
Holder count
Q4 2024Q2 20251
Aggregate reported value
Q4 2024Q2 2025$1.36M
Quarterly aggregation
QuarterHoldersΔ holdersAggregate valueTotal shares
Q2 2025 1 +0 $1.36M 1.38M
Q4 2024 1 — $1.01M 1.03M